Nephrology JC078: Glomerular And Tubulo-interstitial Diseases And Acute Kidney Injury Flashcards

1
Q

***Renal parenchymal disease (GN)

A

Renal parenchyma:
- Functional tissue of kidney, consisting of ***Nephrons (basic unit)

Classification of glomerulonephritis by ***glomerular cellularity (Proliferative / Non-proliferative) in kidney biopsy

Primary glomerular diseases (i.e. no cause found)
- Proliferative
1. IgA nephropathy (IgAN)
2. Membranoproliferative GN (MPGN)
3. Crescentic GN
4. IgM nephropathy

  • Non-proliferative
    1. Minimal change nephrotic syndrome
    2. Membranous nephropathy
    3. Focal segmental glomerulosclerosis (FSGS)
    4. Thin membrane disease (TBMD)

—> ALL above terms are ***morphological description under microscope

Secondary glomerular diseases
- Proliferative
1. Lupus nephritis
2. Post-streptococcal GN
3. Hep B / C-related MPGN
4. Systemic vasculitis
5. Goodpasture syndrome

  • Non-proliferative
    1. Diabetic nephropathy
    2. Hypertensive nephrosclerosis
    3. Amyloidosis
    4. Light/Heavy chain deposition disease
    5. Alport syndrome
    6. Infection-related membranous glomerulopathy
    7. HIV nephropathy (FSGS / Collapsing glomerulopathy)
    8. Drug-induced glomerulopathy
    9. Malignancy-associated nephropathy
    10. Reflux nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of Glomerular disease

A

Usually by different patterns of histologic injury seen on biopsy

NO single classification is ideal
- one histologic pattern can have **multiple etiologies (e.g. membranous pattern can be idiopathic / due to lupus / viral hepatitis infection)
- one etiology may produce a **
variety of histologic patterns (e.g. lupus nephritis (class 1-6 with different morphological pattern), IgAN, HBV infection)
- one histologic pattern can have ***multiple clinical presentations (e.g. IgA nephropathy may present with asymptomatic microscopic haematuria / synpharyngitic gross haematuria / RPGN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

***Clinical features of Renal parenchymal disorders

A

Glomerulonephritis (present with 1 of 6 clinical syndromes):
1. Asymptomatic microscopic haematuria / proteinuria
2. Macroscopic haematuria
3. Acute nephritic syndrome
4. Nephrotic syndrome
5. Rapidly progressive glomerulonephritis
6. Chronic glomerulonephritis / CKD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Asymptomatic haematuria
A

Features:
- Either Macroscopically / Microscopically (>2 RBC per high power field in spun urine) detected blood in urine, usually **dysmorphic
—> irregularities of RBC membrane
—> **
acanthocytes (with ring-formed cell bodies with blebs of different size / shape)
—> may clump together to form **RBC cast (tubular shape) when pass through tubules
- Detected through health check, pre-employment, pre-school etc.
- Usually with **
normal GFR + **no evidence of systemic disease
- Variable degrees of **
proteinuria may be present, usually ***<1 g/day (low-grade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Macroscopic haematuria

A

**Episodic **painless macroscopic haematuria associated with glomerular disease
—> often ***brown / smoky urine rather than red
—> blood clots are unusual (clots usually indicate Lower UT bleeding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

***DDx of Haematuria

A

Urological conditions:
1. Stones
2. Tumours

Renal conditions:
1. **Glomerulonephritis
- **
IgA nephropathy —> usually Gross
- **Alport syndrome (Hereditary nephritis) (hearing deficit common) —> usually Gross
- **
Thin membrane disease (TBMD) (Benign familial haematuria)
2. ***Acute interstitial nephritis
3. Polycystic kidney disease

Infection:
1. Cystitis
2. TB
3. Schistosomiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alport syndrome

A
  • Mutations of ***Type 4 collagen genes
  • Cochlea
    —> ↓ Adhesion of Organ of Corti (auditory sensory cells) to Basilar membrane via defective alpha-3-4-5 type 4 collagen
    —> Deafness

Inheritance:
- ***X-linked in 80%
- No male-to-male transmission
- Women with X-linked Alport syndrome are heterozygous carriers of the disease mutation
—> almost all have some degree haematuria + some develop renal failure (∵ lyonisation, a random X-inactivation phenomenon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

***Evaluation of Haematuria

A
  1. IgAN
  2. Alport’s syndrome (Hereditary nephritis) (hearing deficit common)
  3. Thin membrane disease (Benign familial haematuria)
    —> Above conditions can be distinguished by **history + **urinalysis of family members

History taking:
1. **Gross haematuria
- common in **
IgAN (haematuria often occur after an episode of mucosal infection e.g. URTI) + ***Alport syndrome
- unusual in TBMD (<10%)

  1. ***Family history of CKD
    - Alport syndrome (renal failure / deafness (primarily in males), X-linked dominant mode of inheritance)
    - IgAN (run in families but no particular mode of inheritance ∵ polygenic / multi-hit theory)
  2. ***Electron microscopy of Membrane thickness
    - TBMD: 150-225 nm (normal 300-400 nm) —> cannot guard against RBC leakage from blood to urine —> microscopic haematuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Investigations for Haematuria

A
  1. RFT
  2. ***Urine culture / cytology / AFB
  3. ***Urinalysis
  4. ***Urine microscopy (crystal for presence of stone)
  5. KUB
  6. ***USG / Doppler
    - stones with acoustic shadowing
  7. Cystoscopy (look for bladder space occupying lesion)
  8. IVP (IV pyelogram) / RP (retrograde pyelogram)
  9. CT urogram (high radiation exposure: 2x IVP)
  10. ***Pure tone audiometry (Alport syndrome)
  11. **Renal biopsy (to ascertain cause)
    - usually not required in isolated haematuria
    - indicated with concomitant **
    significant proteinuria (e.g. >1 g/day)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Isolated proteinuria
A

Normal <150 mg (40-80)
- ***10mg is albumin

Urine albumin:
- Normal **<20 mg/day (15 ug/min)
- Persistent microalbuminuria: **
30-300 mg/day (20-200 ug/min)
- Macroalbuminuria / Overt proteinuria: ***>=300 mg/day (200 ug/min) —> standard dipstick becomes +ve

(Nephrotic syndrome: >3.5g protein / day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

***Evaluation of Proteinuria

A
  1. Dipstix
    - screening for detecting proteinuria
    - ***>=1+ should undergo confirmation by quantitative measurement
    - measures albumin concentration via a colourimetric reaction between albumin and tetrabromophenol blue —> produce different shades of green according to concentration of albumin in sample
    —> trace: 15-30 mg/dL
    —> 1+: 30-100
    —> 2+: 100-300
    —> 3+: 300-1000
    —> 4+: >1000
  2. Spot urine (convenient + accurate as Timed urine)
    - **Urine protein-to-creatinine ratio
    —> Normal: <0.2 mg/mg
    —> **
    >3.5 mg/mg: Nephrotic range for proteinuria
    - first morning urine preferred, random sample acceptable
  3. Timed urine (24 hour)

Patients with >=2 positive quantitative tests (spaced by 1-2 weeks)
—> diagnosed as ***Persistent proteinuria
—> Further evaluation needed

Monitoring proteinuria:
- by Quantitative measurements (rather than Dipstix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pitfalls in Proteinuria assessment

A

False positive results:
1. **Strenuous exercise within 24 hours
2. Concomitant systemic infection
3. **
UTI
4. Fever
5. **Pregnancy (kidney bloodflow markedly ↑)
6. **
Marked HT
7. Haematuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Orthostatic proteinuria

A
  • ↑ Protein excretion in upright position but not when supine
  • Mechanism unclear, ?Neurohumoral activation
  • ***Benign condition in young subjects
  • Proteinuria <1 g/day, but may >3 g/day
  • ***Split urines (Erect + Supine urine) are collected to identify this condition
  • Requires no further evaluation / specific therapy —> ***resolves over time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

***3. Acute nephritic syndrome

A

Features:
- **Abrupt onset of **macroscopic haematuria
- **Oliguria
- **
Acute renal failure (abrupt ↓ in renal function)
- **Fluid retention (edema + HT)
- Urinary protein **
<3 g/day

Disease
1. Post-streptococcal GN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Post-streptococcal GN

A

Children 2-10 yo predominantly

Pathogenesis:
- Streptococcal Ag “planted” in glomerulus during early phase of streptococcal infection
—> 10-14 days later by host immune response against Streptococcal Ag in glomerulus
—> formation of ***Immune complexes
—> kidney damage

Clinical picture:
- Acute, reversible disease characterised by **spontaneous recovery in vast majority
- **
Gross haematuria, Oliguria, HT, Edema: develop ***7 days - 12 weeks after streptococcal infection (throat / skin)
- Spontaneous resolution of clinical manifestations generally rapid
—> diuresis resolves within 1-2 weeks
—> renal function return normal within 4 weeks

Investigation:
1. Total haemolytic complement activity / **C3 concentration ↓
- persistently low C3 >8 weeks —> possibility of **
Lupus nephritis / **MPGN
2. **
Anti-Streptolysin O ↑ (but not all strains produce Streptolysin O)
3. Diffuse hypercellularity on biopsy (i.e. ***Proliferative)
4. Subepithelial deposits (Immune complex) on electron microscope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of Acute nephritic syndrome

A

Depends on etiology

Acute Post-streptococcal GN:
1. **Penicillin (may be indicated)
2. During Oliguric phase
- **
Supportive therapy (fluid / salt restriction, Anti-HT)
- +/- ***Temporary dialysis may be needed (grossly edematous, high serum urea, creatinine)

17
Q

***4. Nephrotic syndrome

A

Features:
1. Massive proteinuria (>3.5 g/day or 40 mg/hr/m^2 in children)
2. Generalised edema
3. Hypoalbuminaemia (
<30 g/L)
4. Hyperlipidaemia + Lipiduria (varying degrees)

Clinical presentations:
1. **Periorbital edema in early morning (resolves during day under gravity)
2. **
Dependent ankle edema
3. **Xanthelasma
4. **
Muehrcke’s bands (transverse white bands grew on nails during a transient period of hypoalbuminaemia)

Electron microscopy:
- Primary, Secondary, Tertiary, Quaternary processes of podocytes are lost —> ***Effacement of podocytes

Causes:
Primary renal diseases:
1. FSGS
2. Membranous GN
3. Minimal change disease
4. MPGN
5. IgAN (occasionally)

Systemic diseases:
1. DM Type 2
2. SLE
3. Secondary membranous nephropathy
- **Infection: HBV, HCV, HIV, malaria, syphilis
- **
Malignancy: lymphoma, adenocarcinoma (lung, GI tract, breast), myeloma
- ***Drugs: penicillamine, gold, mercury, NSAIDs, probenecid
4. Amyloidosis
(5. Cryoglobulinaemia
6. Renal vein thrombosis
7. Kimura’s disease (JC Teaching Clinic))

18
Q

Investigation of Nephrotic syndrome

A
  1. CBC
  2. Renal biochemistry
  3. ***Urine protein quantification (spot / 24 hour urine)
  4. ***FG
  5. ***Immune markers
  6. Ig pattern
  7. HBsAg
  8. Anti-HCV
  9. Anti-HIV
  10. **Anti-PLA2R (Anti-Phospholipase A2 receptor: present in 70% of primary **membranous nephropathy, not present in normal people)
  11. ***Tumour screening (for >50 yo): CXR, Stool OB, Other tumour markers
19
Q

***Treatment of Nephrotic syndrome

A
  1. Corticosteroid (mainstay)

2nd line:
2. **Calcineurin inhibitor (steroid-resistant / steroid-dependent cases —> **steroid-sparing effects)
- Tacrolimus
- Cyclosporin

  1. Other forms of treatment
20
Q

Complications of Nephrotic syndrome (JC Teaching Clinic)

A
  1. Hyperlipidaemia and lipiduria
  2. Infection
  3. Vascular thrombosis
  4. ARF
  5. Protein malnutrition
  6. Hypovolaemia
21
Q

***5. Rapidly progressive glomerulonephritis (RPGN)

A

Features:
- **Signs of GN (Haematuria, Proteinuria, RBC casts)
- **
Rapid decline in renal function —> can lead ESRD within days to weeks

Pathological hallmark:
- Presence of ***Cellular crescents in glomerulus (severe inflammation in kidney)

  • Beware of other organ system involvement e.g. pulmonary haemorrhage (Goodpasture’s) / hepatic failure (leptospirosis)

Causes:
1. **Pauci-immune GN (systemic vasculitis) (absence of immune staining)
2. **
Anti-GBM disease / Goodpasture syndrome (pulmonary capillary BM also destroyed by Ab —> pulmonary haemorrhage)
3. **Crescentic IgAN
4. **
Acute post-infectious GN
5. Multisystem diseases
- Systemic vasculitis
- Cryoglobulinaemia (associated with active Hep C infection / haematological diseases e.g. dysproteinaemia)
- SLE

22
Q

Investigations of RPGN

A
  1. CBC
  2. Renal biochemistry
  3. Urine protein quantification
  4. Urine sediments
  5. ***Autoimmune markers
    - ANCA, Anti-GBM, ANA, Anti-dsDNA, C3/C4
  6. ***CXR
  7. ***DLCO (pulmonary function for Goodpasture’s)
23
Q

Treatment of RPGN

A

According to etiology
1. **Corticosteroids +/- Immunosuppressants
2. **
Plasmapheresis (if Anti-GBM Ab present)

24
Q

***6. Chronic GN

A

Syndrome manifested by progressive kidney failure in patients with **glomerular inflammation, proteinuria, haematuria, HT (all previously undetected)
- Important cause of CKD
- Kidneys show variable degrees of **
atrophy
- Blood tests: ***Very high creatinine
- Urinalysis: Protein + Blood

25
Investigations of Chronic GN
Ascertain ***chronic nature of disease 1. CBC - ***Normochromic normocytic anaemia 2. Renal biochemistry - ↑ Urea, Creatinine, ***PO4 - ***↓ Ca - +/- ↑ K - Metabolic acidosis 3. Urine protein quantification 4. USG (↓ kidney size, ↑ echogenicity) 5. Renal biopsy (usually unnecessary, ∵ only show fibrosis, glomerulosclerosis —> cannot identify underlying cause anyway)
26
Treatment of Chronic GN
1. Supportive therapy 2. Minimise metabolic disturbance + complications 3. Renal replacement therapy (if approaching stage 5 CKD)
27
***Tubulointerstitial diseases (TIN)
- Anatomically >95% of kidney - Acute TIN may cause important renal dysfunction (***~5-15% acute renal failure causes) - If left unchecked, Chronic TIN is major pathway leading to ***CKD Clinical manifestations (∵ Interstitial inflammation + Tubular dysfunction): 1. Loss of renal function 2. Abnormal urine sediment (e.g. WBC (but without infection), proteinuria) 3. ***Electrolyte disturbance 4. ***Acid-base disorders
28
***Entities of TIN
1. ***Acute TIN - Drugs (e.g. Penicillins, NSAID, PPI, Mesalazine (delayed) (Davidson)) - Infections (e.g. pyelonephritis, leptospirosis, TB, Hantavirus (Davidson)) - Autoimmune disease 2. ***Chronic TIN - Etiology unknown Davidson: - ANY causes of Acute TIN if persistent - Drugs (e.g. Tenofovir, Lithium, Ciclosporin, Tacrolimus, Analgesic nephropathy) - Autoimmune disease (e.g. SLE, Sjogren's) - Metabolic (e.g. CaPO4 crystallisation, HypoK, Hyperoxaluria) 3. K-wasting tubular disorders 4. ***Renal tubular acidosis (∵ inability of tubules to excrete H / reabsorb HCO3)
29
***Acute kidney injury
Definition: - Abrupt decrease in kidney function - Even mild, reversible AKI can progress to CKD - AKI viewed as same to Acute lung injury / ACS Characterised by: 1. Abrupt ↓ in GFR over a period of hours / days 2. 50% ↑ SeCr (3. ↑ in some damage markers e.g. NGAL, KIM-1, IL18) Risk factors of AKI: 1. ***Pre-existing CKD 2. ***Diabetic nephropathy 3. Heart failure 4. Liver disease 5. ***Hypovolaemia 6. Age >50 7. Sepsis 8. Trauma 9. Post-operative (e.g. Post-CABG) 10. Cancer
30
Causes of AKI
Various etiologies - May have >=1 of below conditions 1. Pre-renal (>50%) - Prerenal azotaemia (Hypotension, Dehydration, Sepsis, Shock, Heart failure, Hepatorenal syndrome) - Renal artery (Occlusion, Vasculitis) - Small vessel disease (Thrombotic microangiopathy, Renal atheroembolism, Vasculitis) 2. Intrinsic (<50%) - Acute GN (All causes of RPGN) - Acute tubular necrosis (Drugs, Toxins, Ischaemia (from dehydration, hypotension, cardiogenic shock, hypovolaemic shock), Rhabdomyolysis, Radiocontrast) - Acute interstitial nephritis (Drugs, Infection, Autoimmune disease) - Intratubular obstruction (Cast nephropathy, Drugs, Crystalluria) 3. Post-renal (<10%) - Renal vein thrombosis - Obstructive causes (e.g. Ureteric stone, BPH, Neurogenic bladder)
31
Management of AKI
General principles: 1. Rapid + Accurate diagnosis 2. Identify + Reverse underlying cause (e.g. nephrotoxins, sepsis, hypovolaemia, obstruction, cardiogenic) Treatment: 1. ***Diuretics (for fluid overload, acute pulmonary edema) 2. Electrolyte disturbance (***HyperK, ***acidosis): ***Polysulphonate (for binding K in gut), ***D/I drip (drive K into cells, dextrose is buffer for insulin to prevent hypoglycaemia), ***HCO3 3. HCO3 (for acidosis) 4. ***Acute dialysis support - usually ***HD - vascular access - ICU admission if indicated Indications for dialysis (Blue book + SpC Medicine): 1. Severe HyperK 2. Severe Metabolic acidosis 3. Fluid overload (e.g. APO) 4. Uraemia complications (Uraemic encephalopathy / pericarditis)
32
Natural history and progression of Diabetic nephropathy (From GIS + MSS + HNS + HIS + ERS PBL)
First changes - ***Microalbuminuria - ***Glomerular BM thickening —> Microangiopathy - Accumulation of matrix material in mesangium Subsequent changes - ***Heavy proteinuria - Nodular deposits - ***Glomerulosclerosis Pathogenesis: 1. Chronic hyperglycaemia —> ***↑ Mesangial Cell matrix production + apoptosis —> Mesangial cell expansion + injury 2. Glomerular hypertrophy (↑ Renal size) —> ↑ shear stress on glomerular capillary wall 3. Glomerular hyperfiltration (↑ GFR) —> dilatation of afferent arteriole by ***AGEs, Sorbitol, IGF-1 —> ↑ Renal blood flow —> ↑ Intra-glomerular pressure (Intra-glomerular hypertension) 4. Glomerulosclerosis —> ∵ Intra-glomerular hypertension —> ∵ Hyaline narrowing of vessels supplying the glomeruli (Hyaline deposition induced by ischaemic injury) Histology: 1. Diabetic ***Glomerulosclerosis —> ECM deposition in glomeruli 2. ***Mesangial expansion 3. ***GBM thickening 4. ***Arteriolar Hyalinosis / Arteriolosclerosis Consequence: Microalbuminuria Management: 1. Protein restriction 2. Antihypertensive 3. Glycaemic control
33
Contraindications to Renal biopsy (JC Teaching Clinic + SpC Teaching Clinic)
1. ***Uncorrectable bleeding diathesis - check Plt, Clotting profile - stop Antiplatelet, Anticoagulants 2. ***Small kidneys which are generally indicative of chronic irreversible disease - futile + risky due to puncturing a hard fibrotic structure —> bleeding 3. ***Severe hypertension, which cannot be controlled with antihypertensive - one dose of amlodipine —> wait several hours for BP to decrease 4. Multiple, bilateral cysts / renal ***tumour 5. Hydronephrosis 6. Active renal / perirenal ***infection 7. Uncooperative patient 8. Solitary kidney - ∵ in case of several bleeding may need embolisation / nephrectomy
34
Minimal change nephrotic syndrome (MCNS)
“Nephrotic syndrome, normal-looking glomeruli + absence of hypertension, haematuria or azotaemia” Epidemiology: - ***Children: >90% of nephrotic syndrome - Adult: 10-15% of nephrotic syndrome - Elderly: suspect possible underlying malignancy, esp. lymphoid origin (e.g. Hodgkin’s disease) Clinical features: 1. Heavy proteinuria 2. Onset of edema may be insidious / acute, initially affecting periorbital area upon awakening and shifting to the ankles towards the end of day 3. Ascites / Pleural effusion in severe cases Pathology: - Light microscopy demonstrates essentially ***normal glomerular morphology - Immunofluorescence is usually ***negative for immunoglobulins - Only detectable abnormality is ***total effacement of foot processes (podocytes) of visceral epithelial cells shown on ultrastructural examination by ***EM - These morphological alterations are typical of nephrotic syndrome but not specific to MCNS - Some patients with clinical features of MCNS have ***positive mesangial IgM staining, along with mesangial ***proliferative changes - These patients, more likely to also have ***microscopic haematuria and less likely to respond to steroid, are said to have ***IgM nephropathy - Relationship between MCNS, IgM nephropathy, and FSGS is ***poorly defined, but responsiveness to steroid therapy is a shared feature —> ***Continuum of pathology Treatment: 1. Corticosteroid - Adult: Prednisolone started at 1 mg/kg/day (up to max 80 mg/day) —> slowly tailed off over a period of around 4 months - Children: Prednisone at 60 mg/m2/day (up to max 80 mg/day) for 4 to 6 weeks —> 40 mg/m2 every other day for 4 to 6 weeks 2nd line agents 2. Alkylating agents 3. Cyclosporine, Tacrolimus 4. Levamisole - antihelminthic agent with immunomodulatory effects, used alone / in combination with steroid in MCNS in children - well tolerated - SE: neutropenia, rash, liver toxicity
35
Membranous nephropathy
- Most common cause of nephrotic syndrome in adults - Defined by the presence of ***subepithelial immune deposits leading to a spectrum of glomerular capillary wall alterations, most typically the formation of intervening ***"GBM spikes" - Primary vs Secondary - Primary MN is regarded as ***prototypic glomerular disease mediated by ***in situ immune complex formation - Can also occur secondary to autoimmune disease, neoplasia, infection, exposure to certain therapeutic agents Epidemiology: - Most common in Caucasian individuals + Adults - Rare in infants and young children - M:F = 2:1 - Secondary MN most commonly encountered in young children and in individuals >60 yo Clinical features: 1. ***Proteinuria (defining clinical feature of MN) - majority of patients have full nephrotic syndrome 2. Normal RFT (most patients at time of presentation) 3. Microhaematuria (~50%) Secondary MN: - 25% of cases - 4 categories: 1. Autoimmune / Collagen vascular diseases, - SLE (most notably, i.e. membranous lupus nephritis) - RA - Sjogren's syndrome - mCTD - Sarcoidosis - Grave's disease - Hashimoto's thyroiditis 2. Malignancy - Carcinomas of the lung, prostate, breast, GI tract 3. Drugs - Gold - Penicillamine - NSAIDs, COX-2 inhibitors - Captopril 4. Infections - Hepatitis B / C - Syphilis - Malaria - Parasites
36
HBV associated nephropathy
1. Membranous GN 2. Mesangiocapillary glomerulonephritis (MCGN) 3. IgA nephropathy Clinical features: 1. Proteinuria, usually in the nephrotic range 2. Mild to moderate renal impairment (may be present at presentation) Children: - Male preponderance - Nephrotic syndrome most frequent - Transaminase levels are usually normal Adults: - Proteinuria / Nephrotic syndrome - More likely than children to have HT, renal dysfunction, and clinical evidence of liver disease Prognosis: - Children: Favourable; high rates of spontaneous remission - Adults: Worse in patients with nephrotic range proteinuria and overt hepatitis at presentation Treatment: 1. General measures for CKD - Optimise BP control - Reduce proteinuria with ACEI / ARB - Control lipid levels - Sodium restriction - Quit smoking - Optimise body weight - Regular exercise 2. Specific measures - Eradication of the underlying HBV by nucleoside analog e.g. Lamivudine